Evaluation Of CNCM LTD Intangible Quality

Intangible assets quality evaluation refers to enhance corporate value as the target,and the overall heterogeneity of intangible assets for businesses,profitability and extent to meet the needs of sustainable development evaluation.Intangible quality assessment enables enterprises to accurately understand the status of intangible assets,and through detailed analysis found that intangible factors leading to quality problems,which made recommendations for improvements for specific issues.Firstly,the concept of intangible assets and intangible quality assessment to define,and related theory analysis,combined with the special nature of the pharmaceutical industry of intangible assets,summed up the contents of the pharmaceutical industry quality evaluation of intangible assets,intangible quality while referring to predecessors research,construction of the intangible quality evaluation system.Quality evaluation of intangible assets 100 listed pharmaceutical companies cluster analysis,quality evaluation of intangible assets derived pharmaceutical industry standards,and the pharmaceutical industry intangible quality evaluation method will be described.Pharmaceutical industry intangible quality evaluation index system,evaluation criteria and evaluation methods constitute the pharmaceutical industry intangible quality evaluation model.Then use the evaluation mode,respectively Sinopharm shares the overall quality of intangible assets and evaluate the quality of various types of intangible assets,results of evaluation findings:Sinopharm shares less intangible technological innovation capacity and market competitiveness of medium-poor sustainable development capacity;poor knowledge of intangible assets quality,medium quality of human resources,poor quality of intangible market class.For intangible assets and quality problems of suggestions for improvements.The possible contribution of this paper at are:1.Evaluation of specialized intangible quality 2.Building the pharmaceutical industry 3.intangible quality evaluation model constructed using quality evaluation model for Sinopharm shares were specific evaluation of intangible assets for the future invisible asset quality evaluation model and its application to do a little modest.